Medicure Inc. (CVE:MPH – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$0.87 and traded as low as C$0.68. Medicure shares last traded at C$0.68, with a volume of 4,500 shares changing hands.
Medicure Price Performance
The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The firm has a market capitalization of C$7.10 million, a P/E ratio of -3.49 and a beta of 0.90. The business has a fifty day moving average of C$0.79 and a 200-day moving average of C$0.87.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- Using the MarketBeat Dividend Tax Calculator
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Upcoming IPO Stock Lockup Period, Explained
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What is the Euro STOXX 50 Index?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
